Telomir Pharmaceuticals, Inc. cotiza a 1.09 USD y tiene una capitalización bursátil de $80M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-re…
| Periodo | 2026-08 | 2025-11 | 2025-08 | 2025-05 |
|---|---|---|---|---|
| Real | $-0.79 | $-0.03 | $-0.17 | $-0.07 |
| Estimado | $-0.07 | $-0.07 | $-0.08 | $-0.10 |
| Sorpresa | -1028.6% | +57.1% | -112.5% | +30.0% |
| Métrica | TELO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -176.1% | -40.4% | -135.7% |
| ROA | -141.8% | -32.0% | -109.8% |
| Current Ratio | 5.14 | 2.84 | +2.30 |
| Debt / Equity | — | 0.28 | — |